Tumor vascularization occurs through several distinct biological processes, which not only
vary between tumor type and anatomic location, but also occur simultaneously within the …

CD93 (also known as complement protein 1 q subcomponent receptor C1qR1 or C1qRp), is
a transmembrane glycoprotein encoded by a gene located on 20p11. 21 and composed of …

Stromal cells (SCs) establish the compartmentalization of lymphoid tissues critical to the
immune response. However, the full diversity of lymph node (LN) SCs remains undefined …

The immature and dysfunctional vascular network within solid tumors poses a substantial
obstacle to immunotherapy because it creates a hypoxic tumor microenvironment that …

Tumor angiogenesis is a key event that governs tumor progression and metastasis. It is
controlled by the complicated and coordinated actions of pro-angiogenic factors and their …

Tumor angiogenesis occurs through regulation of genes that orchestrate endothelial
sprouting and vessel maturation, including deposition of a vessel-associated extracellular …

Mesenchymal stem/stromal cells (MSCs) are multipotent cells involved in numerous
physiological events, including organogenesis, the maintenance of tissue homeostasis …

The C‐type lectin domain (CTLD) group 14 family of transmembrane glycoproteins consist of
thrombomodulin, CD 93, CLEC 14A and CD 248 (endosialin or tumour endothelial marker …

The tumor microenvironment plays a central role in cancer initiation and progression.
CD248 is expressed in tumor-associated stromal cells, particularly fibroblasts and pericytes …

Accurately evaluating tumor neoangiogenesis and conducting precise interventions toward
an immune‐favorable microenvironment are of significant clinical importance. In this study, a …